Mechanism of Action: Copper Chelating Activity
✉ Email this page to a colleague
Drugs with Mechanism of Action: Copper Chelating Activity
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orphalan | CUVRIOR | trientine tetrahydrochloride | TABLET;ORAL | 215760-001 | Apr 28, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Orphalan | CUVRIOR | trientine tetrahydrochloride | TABLET;ORAL | 215760-001 | Apr 28, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Orphalan | CUVRIOR | trientine tetrahydrochloride | TABLET;ORAL | 215760-001 | Apr 28, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Orphalan | CUVRIOR | trientine tetrahydrochloride | TABLET;ORAL | 215760-001 | Apr 28, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rising | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 212238-001 | Feb 20, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 212238-002 | Sep 22, 2023 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
